These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 3496152)

  • 21. Depletion of human NK cells with monoclonal antibodies allows the generation of cytotoxic T lymphocytes without NK-like cells in mixed cultures.
    Strassmann G; Bach FH; Zarling JM
    J Immunol; 1983 Apr; 130(4):1556-60. PubMed ID: 6220056
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adherent lymphokine-activated killer cells in chronic myelogenous leukemia: a benign cell population with potent cytotoxic activity.
    Verfaillie C; Miller W; Kay N; McGlave P
    Blood; 1989 Aug; 74(2):793-7. PubMed ID: 2473805
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Patients with a deficiency of natural killer cell activity lack the VEP13-positive lymphocyte subpopulation.
    Ziegler-Heitbrock HW; Rumpold H; Kraft D; Wagenpfeil C; Munker R; Abo T; Balch CM; LeBien TW
    Blood; 1985 Jan; 65(1):65-70. PubMed ID: 3965053
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of autologous natural killer cells in chronic myelogenous leukemia.
    Pierson BA; Miller JS
    Leuk Lymphoma; 1997 Nov; 27(5-6):387-99. PubMed ID: 9477121
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Generation of MHC-nonrestricted and restricted oncolytic subsets from human bone marrow.
    Fuchshuber PR; Lotzová E; Savary CA
    Cell Immunol; 1992 Jan; 139(1):30-43. PubMed ID: 1728969
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of a clonally restricted 90 kD heterodimer on two human cloned natural killer cell lines. Its role in cytotoxic effector function.
    Hercend T; Meuer S; Brennan A; Edson MA; Acuto O; Reinherz EL; Schlossman SF; Ritz J
    J Exp Med; 1983 Nov; 158(5):1547-60. PubMed ID: 6355362
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Natural killer (NK)-cell activity in sorted subsets of peripheral blood mononuclear cells from patients with severe combined immunodeficiency.
    ten Berge RJ; Schellekens PT; Budding-Koppenol A; Dooren LJ; Vossen JM
    J Clin Immunol; 1987 May; 7(3):198-202. PubMed ID: 3597714
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clonal heterogeneity in the requirement for T3, T4, and T8 molecules in human cytolytic T lymphocyte function.
    Moretta A; Pantaleo G; Mingari MC; Moretta L; Cerottini JC
    J Exp Med; 1984 Mar; 159(3):921-34. PubMed ID: 6421984
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of human large granular lymphocyte subpopulations: comparison of the phenotype of NK cells and of interleukin 2-dependent progenitors of cytolytic effector cells.
    Allavena P; Klein R; Ortaldo JR
    Nat Immun Cell Growth Regul; 1985; 4(1):7-20. PubMed ID: 3875792
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phenotypic characteristics of human natural killer cells.
    Perussia B; London L; Trinchieri G
    Biomed Pharmacother; 1985; 39(1):13-8. PubMed ID: 3875369
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phenotypic and functional characterization of HTLV positive neoplastic T cells cultured with interleukin-2--I. Retention of morphology, phenotype and selective cytotoxic properties in long term culture.
    Vyth-Dreese FA; de Vries JE
    Leuk Res; 1984; 8(1):1-14. PubMed ID: 6321859
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of an antigen expressed by human natural killer cells.
    Griffin JD; Hercend T; Beveridge R; Schlossman SF
    J Immunol; 1983 Jun; 130(6):2947-51. PubMed ID: 6574190
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro propagation of cultured human natural killer cells expressing the HNK-1 differentiation antigen and spontaneous cytotoxic function.
    Abo T; Balch CM
    Eur J Immunol; 1983 May; 13(5):383-9. PubMed ID: 6406236
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Heterogeneity of natural killer lymphocyte abnormalities in colon cancer patients.
    Balch CM; Tilden AB; Dougherty PA; Cloud GA; Abo T
    Surgery; 1984 Jan; 95(1):63-70. PubMed ID: 6581546
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A clonal analysis of human peripheral blood lymphocytes displaying natural killer-like activity.
    Roberts K; Moore M
    Eur J Immunol; 1985 May; 15(5):448-56. PubMed ID: 3873338
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of Hsp70 and HLA-E on the killing of leukemic blasts by cytokine/Hsp70 peptide-activated human natural killer (NK) cells.
    Stangl S; Gross C; Pockley AG; Asea AA; Multhoff G
    Cell Stress Chaperones; 2008; 13(2):221-30. PubMed ID: 18759005
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lysis of tumor cells by CD3+4-8-16+ T cell receptor alpha beta- clones, regulated via CD3 and CD16 activation sites, recombinant interleukin 2, and interferon beta 1.
    van de Griend RJ; Tax WJ; van Krimpen BA; Vreugdenhil RJ; Ronteltap CP; Bolhuis RL
    J Immunol; 1987 Mar; 138(5):1627-33. PubMed ID: 2949018
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High lytic activity against human leukemia cells after activation of allogeneic NK cells by IL-12 and IL-2.
    Uharek L; Zeis M; Glass B; Steinmann J; Dreger P; Gassmann W; Schmitz N; Müller-Ruchholtz W
    Leukemia; 1996 Nov; 10(11):1758-64. PubMed ID: 8892679
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The relationship of HNK-1 (Leu 7) and VEP13 antigens on human cells mediating natural killing.
    Rumpold H; Kraft D; Gastl G; Huber C
    Clin Exp Immunol; 1984 Sep; 57(3):703-9. PubMed ID: 6467685
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clonal analysis of T lymphocytes in spleens from patients with Hodgkin's disease. Frequent occurrence of unusual T4-positive cells which co-express cytolytic activity and production of interleukin-2.
    Romagnani S; Maggi E; Parronchi P; Macchia D; Del Prete GF; Rossi-Ferrini PL; Ricci M; Moretta L
    Int J Cancer; 1986 Mar; 37(3):343-9. PubMed ID: 3081452
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.